Porton Biopharma
Bosch Filling Line
-
£1.3m
-
180m2
-
43 weeks
Porton Biopharma has a rich history in the development and manufacture of biopharmaceuticals for a wide variety of diseases, including Erwinase® - a life-saving drug used to treat Acute Lymphoblastic Leukaemia (ALL), a type of cancer that particularly affects children.
In order to scale-up the manufacture of this life-saving product, T-SQUARED worked with Porton Biopharma to replace a highly labour-intensive manual production process with a fully validated biopharmaceutical filling suite. With a filling accuracy of more than 99.9%, the new line covers the entire process, from washing, depyrogenation and filling to stoppering, freeze-drying and capping.
With such an expensive product as Erwinase, it is crucial to not waste a drop. Every vial only contains one millilitre of product, which means it must be filled with the greatest accuracy.
The T-SQUARED team of design, construction and validation experts delivered its full turnkey service on this project, managing and delivering all design, procurement, construction and fit-out services throughout this important world-class facility.
From concept to completion, T-SQUARED’s multi-disciplined team provided us with design and installation services for the complex reconfiguration of Porton Biopharma’s biopharmaceutical sterile filling suite. The quality of installation, with managed partners by T-SQUARED, is indeed world-class - a completed install that Porton Biopharma is happy to show to partners and associates.
